Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury

References

• Kraus JF, MacArthur DL, Silverman TA, Jayaraman N. Epidemiology of brain injury. In: Narayan RK, Wilberger JE Jr, Povlishock JT, editors. Neurotrauma. New York: McGraw-Hill; 1996. p 13–30
   Google Scholar
• Kadhim HJ, Duchateau J, Sébire G. Cytokines and brain injury: Invited review. Journal of Intensive Care Medicine 2008;23:236–249
   PubMedGoogle Scholar
• Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nature Reviews Neuroscience 2001;2:734–744
   PubMed Web of Science ®Google Scholar
• Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, McIntosh TK. The duality of the inflammatory response to traumatic brain injury. Molecular Neurobiology 2001;24:169–181
   PubMed Web of Science ®Google Scholar
• Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury 2007;38:1392–1400
   PubMed Web of Science ®Google Scholar
• Lloyd E, Somera-Molina K, Van Eldik LJ, Watterson DM, Wainwright MS. Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. Journal of Neuroinflammation 2008;5:28
   PubMed Web of Science ®Google Scholar
• McClain CJ, Cohen D, Ott L, Dinarello CA, Young B. Ventricular fluid interleukin-1 activity in patients with head injury. Journal of Laboratory & Clinical Medicine 1987;110:48–54
   PubMedGoogle Scholar
• Chiaretti A, Genovese O, Aloe L, Antonelli A, Piastra M, Polidori G, Di Rocco C. Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nervous System 2005;21:185–194
   PubMed Web of Science ®Google Scholar
• Lu KT, Wang YW, Yang JT, Yang YL, Chen HI. Effect of interleukin-1 on traumatic brain injury-induced damage to hippocampal neurons. Journal of Neurotrauma 2005;22:885–895
   PubMed Web of Science ®Google Scholar
• Arand M, Melzner H, Kinzl L, Brückner UB, Gebhard F. Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans. Langenbeck’s Archives of Surgery 2001;386:241–248
   PubMed Web of Science ®Google Scholar
• Whalen MJ, Carlos TM, Kochanek PM, Wisniewski SR, Bell MJ, Clark RS, DeKosky ST, Marion DW, Adelson PD. Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Critical Care Medicine 2000;28:929–934
   PubMedGoogle Scholar
• Gopcevic A, Mazul-Sunko B, Marout J, Sekulic A, Antoljak N, Siranovic M, Ivanec Z, Margaritoni M, Bekavac-Beslin M, Zarkovic N. Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury. Tohoku Journal of Experimental Medicine 2007;211:387–393
   PubMedGoogle Scholar
• Shimonkevitz R, Bar-Or D, Harris L, Dole K, McLaughlin L, Yukl R. Transient monocyte release of interleukin-10 in response to traumatic brain injury. Shock 1999;12:10–16
   PubMedGoogle Scholar
• Hensler T, Sauerland S, Riess P, Hess S, Helling HJ, Andermahr J, Bouillon B, Neugebauer EA. The effect of additional brain injury on systemic interleukin (IL)-10 and IL-13 levels in trauma patients. Inflammation Research 2000;49:524–528
   PubMed Web of Science ®Google Scholar
• Shiozaki T, Hayakata T, Tasaki O, Hosotubo H, Fuijita K, Mouri T, Tajima G, Kajino K, Nakae H, Tanaka H, et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 2005;23:406–410
   PubMed Web of Science ®Google Scholar
• Schneider Soares FM, Menezes de Souza N, Libório Schwarzbold M, Paim Diaz A, Costa Nunes J, Hohl A, Nunes Abreu da Silva P, Vieira J, Lisboa de Souza R, Moré Bertotti M, et al. Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis. Neuroimmunomodulation 2012;19:377–385
   PubMed Web of Science ®Google Scholar
• Buttram SD, Wisniewski SR, Jackson EK, Adelson PD, Feldman K, Bayir H, Berger RP, Clark RS, Kochanek PM. Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. Journal of Neurotrauma 2007;24:1707–1717
   PubMedGoogle Scholar
• Ross SA, Halliday MI, Campbell GC, Byrnes DP, Rowlands BJ. The presence of tumour necrosis factor in CSF and plasma after severe head injury. British Journal of Neurosurgery 1994;8:419–425
   PubMed Web of Science ®Google Scholar
• Crespo AR, Da Rocha AB, Jotz GP, Schneider RF, Grivicich I, Pinheiro K, Zanoni C, Regner A. Increased serum sFas and TNFalpha following isolated severe head injury in males. Brain Injury 2007;21:441–447
   PubMed Web of Science ®Google Scholar
• Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. Journal of Neurotrauma 2000;17:367–388
   PubMed Web of Science ®Google Scholar
• Jarrar D, Wang P, Cioffi WG, Bland KI, Chaudry IH. The female reproductive cycle is an important variable in the response to trauma-hemorrhage. American Journal of Physiology Heart & Circulatory Physiology 2000;279:H1015–1021
   PubMed Web of Science ®Google Scholar
• Ng PC, Lam CW, Li AM, Wong CK, Cheng FW, Leung TF, Hon EK, Chan IH, Li CK, Fung KS, Fok TF. Inflammatory cytokine profile in children with severe acute respiratory syndrome. Pediatrics 2004;113:e7–14
   PubMedGoogle Scholar
• Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, Schlag G, Morganti-Kossmann MC. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. Journal of Cerebral Blood Flow & Metabolism 1997;17:280–289
   PubMed Web of Science ®Google Scholar
• Mussack T, Biberthaler P, Kanz KG, Wiedemann E, Gippner-Steppert C, Mutschler W, Jochum M. Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Critical Care Medicine 2002;30:2669–2674
   PubMed Web of Science ®Google Scholar
• McKeating EG, Andrews PJ, Signorini DF, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. British Journal of Anaesthesia 1997;78:520–523
   PubMed Web of Science ®Google Scholar
• Kushi H, Saito T, Makino K, Hayashi N. IL-8 is a key mediator of neuroinflammation in severe traumatic brain injuries. Acta Neurochirurgica Supplement 2003;86:347–350
   PubMedGoogle Scholar
• Seekamp A, van Griensven M, Lehmann U, Molituris U, Hildebrandt F, Pohlemann T. Serum IL-6, IL-8 and IL-10 levels in multiple trauma compared to traumatic brain injury and combined trauma. European Journal of Trauma 2002;28:183–189
   Google Scholar
• Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 1991;147:3815–3822
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. Journal of Experimental Medicine 1991;174:1209–1220
   PubMed Web of Science ®Google Scholar
• Bell MJ, Kochanek PM, Doughty LA, Carcillo JA, Adelson PD, Clark RS, Wisniewski SR, Whalen MJ, DeKosky ST. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. Journal of Neurotrauma 1997;14:451–457
   PubMedGoogle Scholar
• Maier B, Schwerdtfeger K, Mautes A, Holanda M, Müller M, Steudel WI, Marzi I. Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock 2001;15:421–426
   PubMedGoogle Scholar
• Stensballe J, Christiansen M, Tønnesen E, Espersen K, Lippert FK, Rasmussen LS. The early IL-6 and IL-10 response in trauma is correlated with injury severity and mortality. Acta Anaesthesiologica Scandinavica 2009;53:515–521
   PubMed Web of Science ®Google Scholar
• Neidhardt R, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, Ertel W. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. Journal of Trauma 1997;42:863–871
   PubMedGoogle Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095–2147
   PubMed Web of Science ®Google Scholar
• Sawada M, Suzumura A, Hosoya H, Marunouchi T, Nagatsu T. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. Journal of Neurochemistry 1999;72:1466–1471
   PubMed Web of Science ®Google Scholar
• Simi A, Tsakiri N, Wang P, Rothwell NJ. Interleukin-1 and inflammatory neurodegeneration. Biochemical Society Transactions 2007;35:1122–1126
   PubMed Web of Science ®Google Scholar
• Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Brückner UB. Is interleukin 6 an early marker of injury severity following major trauma in humans? Archives of Surgery 2000;135:291–295
   PubMedGoogle Scholar
• Dalla Libera A, Regner A, De Paoli J, Centenaro L, Martins TT, Simon D. IL-6 polymorphism associated with fatal outcome in patients with severe traumatic brain injury. Brain Injury 2011;25:365–369
   PubMed Web of Science ®Google Scholar
• Singhal A, Baker AJ, Hare GM, Reinders FX, Schlichter LC, Moulton RJ. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. Journal of Neurotrauma 2002;19:929–937
   PubMed Web of Science ®Google Scholar
• Winter CD, Pringle AK, Clough GF, Church MK. Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain 2004;127:315–320
   PubMed Web of Science ®Google Scholar
• Kalabalikis P, Papazoglou K, Gouriotis D, Papadopoulos N, Kardara M, Papageorgiou F, Papadatos J. Correlation between serum IL-6 and CRP levels and severity of head injury in children. Intensive Care Medicine 1999;25:288–292
   PubMed Web of Science ®Google Scholar
• Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proceedings of the National Academy of Sciences USA 1993;90:10061–10065
   PubMed Web of Science ®Google Scholar
• Gennarelli TA, Champion HR, Copes WS, Sacco WJ. Comparison of mortality, morbidity, and severity of 59,713 head injured patients with 114,447 patients with extracranial injuries. Journal of Trauma 1994;37:962–968
   PubMedGoogle Scholar